PT  - JOURNAL ARTICLE
AU  - Zhao, Zi-Ai
AU  - Qiu, Jing
AU  - Li, Wei
AU  - Nguyen, Thanh
AU  - Wang, Shouchun
AU  - Shi, Huaizhang
AU  - Wei, Ming
AU  - Wang, Feng
AU  - Li, Di
AU  - Chen, Hui-Sheng
TI  - Intra-arterial tenecteplase during thrombectomy for acute stroke (BRETIS-TNK II): rationale and design
AID  - 10.1136/svn-2023-002377
DP  - 2023 May 11
TA  - Stroke and Vascular Neurology
PG  - svn-2023-002377
4099  - http://svn.bmj.com/content/early/2023/05/10/svn-2023-002377.short
4100  - http://svn.bmj.com/content/early/2023/05/10/svn-2023-002377.full
AB  - Background Our recent pilot study suggests intra-arterial tenecteplase (TNK) during the first pass of endovascular treatment (EVT) seems safe, may increase first-pass reperfusion and good outcome in acute ischaemic stroke (AIS) patients with large-vessel occlusion (LVO).Aims To determine the efficacy and safety of intra-arterial TNK administration during EVT in AIS-LVO patients presenting up to 24 hours from symptom onset.Sample size estimates A maximum of 380 patients are required to test the superiority hypothesis with 80% power according to a two-side 0.05 level of significance, stratified by age, gender, baseline systolic blood pressure, prestroke modified Rankin Scale (mRS), baseline National Institute of Health stroke scale, baseline ASPECTS, time from onset to groin puncture, intravenous thrombolysis before EVT, stroke territory and stroke aetiology.Design Intra-arterial TNK during thrombectomy for acute stroke (BRETIS-TNK II) study is a prospective, randomised, adaptive enrichment, open-label, blinded end point, multicentre study. Eligible AIS-LVO patients are randomly assigned into the experimental group and control group with a ratio of 1:1. The experimental group will be treated with intra-arterial infusion of TNK during EVT. The control group will be treated with standard EVT.Outcome The primary end point is a favourable outcome, defined as an mRS score of 0–2 at 90 days. The primary safety end point is symptomatic intracranial haemorrhage within 48 hours, which is defined as an increase in the National Institutes of Health Stroke Scale score of ≥4 points as a result of the intracranial haemorrhage.Conclusions The results of BRETIS-TNK II will provide evidence for the efficacy and safety of intra-arterial TNK administration during EVT in AIS patients with LVO.No data are available.